
ATLANTA, June 23 (UPI) -- U.S. scientists say they have genetically engineered mice to reproduce many of the non-motor symptoms associated with Parkinson's disease in humans.
Emory University researchers said the classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements. But the genetically engineered mouse model sheds light on common non-motor symptoms, such as digestive and sleep problems, loss of sense of smell and depression.
"These mice are very useful for studying the major non-motor symptoms of Parkinson's because they have them together as a package," Professor Gary Miller said, noting the mice were engineered to be deficient in VMAT2 (vesicular monoamine transporter 2), a protein that helps to store the brain chemicals that Parkinson's patients gradually lose the ability to produce.
The VMAT2-deficient mice could become research tools in the search for medications to treat non-motor symptoms, Miller said, since the mice have delayed emptying of the stomach, they fall asleep more quickly and they have a loss of the sense of smell.
The study that included Tonya Taylor Mike Caudle, Kennie Shepherd, Alireza Noorian, Chad Jackson, Mike Iuvone, David Weinshenker and James Greene appears in the Journal of Neuroscience.
|
|
|
|
|
|
| Additional Science News Stories | |
MIAMI, May 30 (UPI) --
The man who bit off parts of the face of a homeless man in Miami found his victim sleeping in the shade of elevated train tracks, video footage shows.
|
LOS ANGELES, May 30 (UPI) --
Actor Tim Daly said via Twitter his character Pete Wilder won't be on next season of the U.S. medical drama, "Private Practice."
|
ITHACA, N.Y., May 30 (UPI) --
The genome of the tomato has been decoded, a step toward improving yield, nutrition, disease resistance, taste and color of the tomato, U.S. researchers say.
|
TUCSON, May 30 (UPI) --
An Arizona woman said her 8-year-old daughter was humiliated to receive the "Catastrophe Award" from her teacher for giving the most homework excuses.
|
| Stories | Photos | People | Comments |
View Caption